Previous studies have shown that DCAF13 is amplified in various tumors, such as hepatocellular carcinoma (Cao et al., 2017), breast cancer (Wang et al., 2019), and osteosarcoma (Chen et al., 2018). This evidence concerns the gene DCAF13 and breast carcinoma.